Client Successes

Illumina continues critical work in human genomics

Working at the cutting edge of science and medicine, Marshall, Gerstein & Borun's client, Illumina, Inc., created its Genome Analyzer, HiSeq, and MiSeq instruments to sequence DNA at extremely high speeds. When Life Technologies Corp. claimed that the sequencers infringed three of its DNA amplification patents, Marshall Gerstein's trial attorneys led a three-year defense of Illumina. Ultimately, the district court granted our motion for summary judgment disposing of the infringement claims, later affirming its ruling on Life Technologies’ motion for reconsideration. As a result, Illumina can continue with its critical work in the field of human genomics.

Protecting Carbon-Capture Technologies

Marshall Gerstein obtained a successful result for CO2 Solutions, Inc., in an Inter Partes Review (IPR) of one of CO2 Solutions’ patents covering its enzyme-based technology for capturing carbon dioxide from exhaust gas. The Patent Trial and Appeal Board (PTAB) at the U.S. Patent and Trademark Office ruled in favor of CO2 Solutions on four of the five grounds of review, upholding CO2 Solutions’ commercially significant claims of the challenged patent.

CO2 Solutions’ proprietary carbon-capture technologies, as covered by the upheld patent claims and by other patents in CO2 Solutions’ portfolio, provide environmentally-friendly, efficient, and cost-effective methods for reducing carbon emissions. As stated by Evan Price, President and CEO of CO2 Solutions, “We believe this confirms CO2 Solutions’ possession of the least expensive and most environmentally friendly carbon capture technology available on the market.”